Vai al contenuto principale della pagina
Titolo: | Monoclonal antibodies in oncology / / editor, Fatih M. Uckun |
Pubblicazione: | London, England : , : Future Medicine Ltd., , [2013] |
©2013 | |
Edizione: | 1st ed. |
Descrizione fisica: | 1 online resource (85 p.) |
Disciplina: | 615.37 |
Soggetto topico: | Monoclonal antibodies - Therapeutic use |
Antibody-toxin conjugates - Therapeutic use | |
Cancer - Immunotherapy | |
Persona (resp. second.): | UckunFatih M. |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references at the end of each chapters and index. |
Nota di contenuto: | Title page; Copyright page; Contents; Foreword. Monoclonal antibodies in contemporary cancer therapy; 1. mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment; 2. mAbs targeting CTLA-4 and clinical outcomes; 3. mAbs targeting VEGF/VEGFR and clinical outcomes in cancer treatment; 4. mAbs targeting RANKL in bone metastasis treatment; 5. Novel monoclonal antibody-based therapies for leukemia; Index |
Sommario/riassunto: | Monoclonal antibodies (mAbs) have been developed to improve the treatment outcome of cancer patients undergoing therapy according to multimodality regimens without a significant increase of treatment-associated toxicity. This five-chapter book provides examples where mAbs that have become part of the standard of care in cancer patients and cancer types that have responded to mAbs |
Titolo autorizzato: | Monoclonal antibodies in oncology |
ISBN: | 1-78084-327-5 |
1-78084-222-8 | |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910817774203321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |